Definitive Health Sees FY24 Revenue $63M-$65M Vs $65.77M Estimate
Author: Benzinga Newsdesk | February 28, 2024 05:45pm
Business Outlook
Based on information as of February 28, 2024, the Company is issuing the following financial guidance. This guidance includes the effect of the acquisition of the Carevoyance product suite.
First Quarter 2024:
- Revenue is expected to be in the range of $63.0 – $65.0 million, a 6-10% increase year over year.
- Adjusted Operating Income is expected to be in the range of $18.0 – $19.0 million.
- Adjusted EBITDA is expected to be in the range of $19.5 – $20.5 million.
- Adjusted Net Income is expected to be $12.0 – $13.0 million.
- Adjusted Net Income Per Diluted Share is expected to be $0.07 – $0.08 per share on approximately 157.4 million weighted-average shares outstanding.
Posted In: DH
